Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis

HLA-DRB1 shared epitope risk alleles are the strongest genetic risk factors for rheumatoid arthritis (RA) and potential biomarkers for treatment response to biological disease-modifying antirheumatic drugs (bDMARDs). This study aimed to investigate the association between treatment response and indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Mariko, Nagafuchi, Yasuo, Ota, Mineto, Tsuchiya, Haruka, Tateishi, Shoko, Kanda, Hiroko, Fujio, Keishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502099/
https://www.ncbi.nlm.nih.gov/pubmed/37709837
http://dx.doi.org/10.1038/s41598-023-42324-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502099/
https://www.ncbi.nlm.nih.gov/pubmed/37709837
http://dx.doi.org/10.1038/s41598-023-42324-6

Ejemplares similares